176 related articles for article (PubMed ID: 35678885)
21. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
22. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
[TBL] [Abstract][Full Text] [Related]
23. Integrated Chip-Seq and RNA-Seq Data Analysis Coupled with Bioinformatics Approaches to Investigate Regulatory Landscape of Transcription Modulators in Breast Cancer Cells.
Ramos J; Felty Q; Roy D
Methods Mol Biol; 2020; 2102():35-59. PubMed ID: 31989549
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
[TBL] [Abstract][Full Text] [Related]
25. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.
Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer.
Wang C; Xu K; Wang R; Han X; Tang J; Guan X
J Exp Clin Cancer Res; 2021 Nov; 40(1):370. PubMed ID: 34801088
[TBL] [Abstract][Full Text] [Related]
27. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
Ma X; Zhang Y; Kang Y; Li L; Zheng W
Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
[TBL] [Abstract][Full Text] [Related]
28. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
Chen Y; Wu N; Liu L; Dong H; Liu X
J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
[TBL] [Abstract][Full Text] [Related]
29. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
[TBL] [Abstract][Full Text] [Related]
30. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
31. Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
Li L; Xiong Y; Wang N; Zhu M; Gu Y
Clin Breast Cancer; 2022 Jul; 22(5):478-490. PubMed ID: 35279406
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
33. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
[TBL] [Abstract][Full Text] [Related]
34. β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.
Tang W; Li M; Qi X; Li J
Cancer Res Treat; 2020 Oct; 52(4):1084-1102. PubMed ID: 32599982
[TBL] [Abstract][Full Text] [Related]
35. Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: Colocalization of ALDH and CD44.
Kuo YC; Wang LJ; Rajesh R
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():362-372. PubMed ID: 31147008
[TBL] [Abstract][Full Text] [Related]
36. Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease.
Das JK; Felty Q
J Mol Neurosci; 2015 Mar; 55(3):618-31. PubMed ID: 25129100
[TBL] [Abstract][Full Text] [Related]
37. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
Siddharth S; Das S; Nayak A; Kundu CN
Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions.
Perez CM; Felty Q
Microvasc Res; 2022 May; 141():104337. PubMed ID: 35143811
[TBL] [Abstract][Full Text] [Related]
39. NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties.
Wang LL; Wan XY; Liu CQ; Zheng FM
Mol Med; 2022 May; 28(1):49. PubMed ID: 35508987
[TBL] [Abstract][Full Text] [Related]
40. Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood-Brain Barrier.
Li Y; Shteyman DB; Hachem Z; Ulay AA; Fan J; Fu BM
Cells; 2024 Jan; 13(2):. PubMed ID: 38275815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
